These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21933944)

  • 21. [Pseudomonas aeruginosa colonisation in bronchiectatic patients and clinical reflections].
    Kömüs N; Tertemiz KC; Akkoçlu A; Gülay Z; Yilmaz E
    Tuberk Toraks; 2006; 54(4):355-62. PubMed ID: 17203422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of recent antibiotics on nasopharyngeal carriage and lower airway infection in Indigenous Australian children with non-cystic fibrosis bronchiectasis.
    Hare KM; Leach AJ; Morris PS; Smith-Vaughan H; Torzillo P; Bauert P; Cheng AC; McDonald MI; Brown N; Chang AB; Grimwood K
    Int J Antimicrob Agents; 2012 Oct; 40(4):365-9. PubMed ID: 22819151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
    Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
    Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis.
    White L; Mirrani G; Grover M; Rollason J; Malin A; Suntharalingam J
    Respir Med; 2012 Mar; 106(3):356-60. PubMed ID: 22204744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
    Kernen Y; Sauty A; Roulet M
    Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis.
    De Soyza A; Perry A; Hall AJ; Sunny SS; Walton KE; Mustafa N; Turton J; Kenna DT; Winstanley C
    Eur Respir J; 2014 Mar; 43(3):900-3. PubMed ID: 24176999
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease.
    Valderrey AD; Pozuelo MJ; Jiménez PA; Maciá MD; Oliver A; Rotger R
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):20-7. PubMed ID: 20727465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosis.
    Caballero E; Drobnic ME; Pérez MT; Manresa JM; Ferrer A; Orriols R
    Thorax; 2001 Sep; 56(9):669-74. PubMed ID: 11514685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
    Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
    J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis.
    Chalmers JD; Hill AT
    Mol Immunol; 2013 Aug; 55(1):27-34. PubMed ID: 23088941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Specific aspects and care of lung involvement in adults with cystic fibrosis].
    Pin I; Grenet D; Scheid P; Domblides P; Stern M; Hubert D
    Rev Mal Respir; 2000 Aug; 17(3 Pt 2):758-78. PubMed ID: 11076386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
    Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
    J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.
    Hoiby N; Mathiesen L
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):559-66. PubMed ID: 4213329
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.
    Martínez-García MA; Soler-Cataluña JJ; Perpiñá-Tordera M; Román-Sánchez P; Soriano J
    Chest; 2007 Nov; 132(5):1565-72. PubMed ID: 17998359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exacerbations in cystic fibrosis: 4--Non-cystic fibrosis bronchiectasis.
    Chang AB; Bilton D
    Thorax; 2008 Mar; 63(3):269-76. PubMed ID: 18308962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upper airway 2: Bronchiectasis, cystic fibrosis and sinusitis.
    Loebinger MR; Bilton D; Wilson R
    Thorax; 2009 Dec; 64(12):1096-101. PubMed ID: 19952235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
    Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
    Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.